Pharma News India

This patent takes the total count of patents to seven for Venus' antibiotic drug, Vancoplus.

Chandigarh, October 29, 2012: Pharma firm Venus Remedies has receives a patent from Mexico for its antibiotic drug, Vancoplus, to combat a wide range of infections. It is worth noting here that the patent has been granted by Mexico Patent office and is valid till February 2026.


The Company aims to push sales in world's largest drug market following an aggressive launch strategy.

Mumbai, October 23, 2012: Drug firm Lupin plans to launch a minimum of 15 new generic products in the US market by the end of current fiscal with a view to push sales in the world's largest drug market.


OctoPlus' expertise in manufacturing improved injectable pharmaceuticals will support the existing capabilities of Dr Reddy's.

Hyderabad, October 22, 2012: Dr Reddy's Laboratories has picked up the entire equity holding of the Dutch injectable speciality generics maker OctoPlus NV for 27.39 million euros (Rs 191.72 crore) in an all cash deal. It is believed that the recently anno...


Lupin'sKurvelo tablets aim to take a slice of US$ 5 billion worth oral contraceptive market in the US.

New Delhi, October 18, 2012: Lupin has received approval from US Food and Drugs Administration (USFDA) for its oral contraceptive Kurvelo tablets. It is worth noting here that Lupin'sKurvelo tablets are the generic equivalent of Teva'sNordette tablets and are indicated for the pr...


This deal will mark Mitsui's second investment in the Indian pharmaceutical market in a span of two months.

Mumbai, October 16, 2012: The Japan-based Mitsui is looking at investing Rs 250 crore in the domestic drug firm Claris Lifesciences. It has been learned that the Ahmedabad-based company, which is one of India's largest sterile injectables pharmaceutical companies with prese...


Comment!

 
 






* Indicates mandatory field.
Please wait while comments are being sent...